Compare BWBBP & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BWBBP | CERT |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | United States |
| Employees | 325 | N/A |
| Industry | Major Banks | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 1.4B |
| IPO Year | N/A | 2020 |
| Metric | BWBBP | CERT |
|---|---|---|
| Price | $19.19 | $9.12 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $13.25 |
| AVG Volume (30 Days) | N/A | ★ 2.3M |
| Earning Date | N/A | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | N/A | ★ $415,551,000.00 |
| Revenue This Year | N/A | $10.82 |
| Revenue Next Year | N/A | $6.77 |
| P/E Ratio | ★ N/A | $131.28 |
| Revenue Growth | N/A | ★ 11.47 |
| 52 Week Low | N/A | $8.03 |
| 52 Week High | N/A | $15.69 |
| Indicator | BWBBP | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 41.43 | 47.95 |
| Support Level | $18.76 | $8.42 |
| Resistance Level | $20.10 | $9.17 |
| Average True Range (ATR) | 0.24 | 0.39 |
| MACD | -0.10 | 0.08 |
| Stochastic Oscillator | 32.09 | 53.60 |
Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering them a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.